Maple Securities USA’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-4,436
Closed -$275K 215
2014
Q3
$275K Buy
+4,436
New +$282K 0.03% 190
2014
Q2
Sell
-20,045
Closed -$1.23M 276
2014
Q1
$1.23M Sell
20,045
-17,647
-47% -$1.03M 0.11% 45
2013
Q4
$2.16M Sell
37,692
-45,170
-55% -$2.56M 0.16% 57
2013
Q3
$4.41M Buy
82,862
+7,128
+9% +$384K 0.35% 58
2013
Q2
$3.9M Buy
+75,734
New +$3.74M 0.36% 64

Other funds holding MDT

Maple Securities USA's MDT Position: Q4 2014 in Review

Maple Securities USA sold out of Medtronic (MDT) in Q4 2014, closing a stake of 4,436 shares — an estimated $275K sold.

Maple Securities USA first reported a position in MDT in Q2 2013 and held it in 5 quarters. The position peaked at $4.41M in Q3 2013. 1,153 funds tracked by Wall St. Rank hold MDT as of Q4 2014.

  • Maple Securities USA reported no remaining Medtronic position as of Q4 2014 after selling out during the quarter.
  • Maple Securities USA sold 4,436 Medtronic shares in Q4 2014, an estimated $275K.
  • Maple Securities USA first reported a position in Medtronic in Q2 2013 and held it in 5 quarters.
  • Maple Securities USA's Medtronic position peaked at $4.41M in Q3 2013.
  • 1,153 funds tracked by Wall St. Rank held Medtronic as of Q4 2014.

Based on Maple Securities USA's 13F filing for Q4 2014, filed 11 Feb 2015.